Evaluation of hepatitis serology and frequency of viral reactivation in patients with inflammatory arthritis receiving biologic agents: a multicenter observational study

dc.date.accessioned	2023-03-06T07:31:54Z
dc.date.available	2023-03-06T07:31:54Z
dc.date.issued	2023
dc.identifier.citation	Rheumatol Int. 2023 Mar;43(3):523-531. doi: 10.1007/s00296-022-05169-2. Epub 2022 Sep 5.
dc.identifier.uri	https://hdl.handle.net/20.500.12619/100058
dc.relation.isversionof	10.1007/s00296-022-05169-2
dc.relation.isversionof	10.1007/s00296-022-05169-2
dc.title	Evaluation of hepatitis serology and frequency of viral reactivation in patients with inflammatory arthritis receiving biologic agents: a multicenter observational study
dc.relation.journal	Rheumatol Int
dc.identifier.doi	10.1007/s00296-022-05169-2
dc.contributor.author	Capkin E
dc.contributor.author	Capkin E
dc.contributor.author	Yazıcı A
dc.contributor.author	Karkucak M
dc.contributor.author	Durmaz Y
dc.contributor.author	Toprak M
dc.contributor.author	Ataman Ş
dc.contributor.author	Şahin N